NCT05184218 Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19 Status TERMINATED Phase PHASE1
NCT05184192 Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction Status COMPLETED Phase PHASE2
NCT05184166 Hospital Management and 1-year Outcome of Patients Aged 70 Years and Older With Severe COVID-19 Status UNKNOWN Phase N/A
NCT05184127 Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19 Status COMPLETED Phase PHASE2
NCT05184114 Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance Status COMPLETED Phase NA
NCT05184101 Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) Status WITHDRAWN Phase PHASE2/PHASE3
NCT05182567 GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19) Status UNKNOWN Phase PHASE1
NCT05182515 Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies Status UNKNOWN Phase PHASE3
NCT05180500 Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis Status COMPLETED Phase PHASE1
NCT05178238 Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2 Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05178212 Characteristics and Outcomes of Patients With COVID-19 Treated With HFNO and Prone Positioning Status COMPLETED Phase N/A
NCT05175963 Surveillance Among Healthcare Workers for SARS-Coronavirus-2 Infection Status COMPLETED Phase N/A
NCT05175846 INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease Status UNKNOWN Phase N/A
NCT05175716 Organizational Impact of Rapid Screening for COVID-19 by Delocalized Biology in the Birth Room Status COMPLETED Phase N/A
NCT05175677 Study of the Impact of the COVID-19 Pandemic on the Management of Type 2 Diabetic Patients in a Sample in the Paris Region Status COMPLETED Phase N/A
NCT05175625 Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine Status COMPLETED Phase PHASE3
NCT05175339 Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19) Status COMPLETED Phase N/A
NCT05173441 Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients Status UNKNOWN Phase PHASE2